{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:36:46Z","timestamp":1792798606663,"version":"4.5.0"},"reference-count":35,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Region Stockholm","award":["2020-0731"],"award-info":[{"award-number":["2020-0731"]}],"id":[{"id":"https:\/\/ror.org\/02zrae794","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Region Stockholm","award":["2022-0674"],"award-info":[{"award-number":["2022-0674"]}],"id":[{"id":"https:\/\/ror.org\/02zrae794","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Oura Health Oy"},{"name":"Swedish Heart-Lung foundation","id":[{"id":"https:\/\/ror.org\/052261q33","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2022-00834"],"award-info":[{"award-number":["2022-00834"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,3,31]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate if 10 sessions of hyperbaric oxygen treatments (HBOTs) improve short- and long-term health related quality of life, symptoms and physical performance in long covid patients compared with placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Parallel, randomised, placebo-controlled, double-blind trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Single-centre, university hospital, Sweden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Previously healthy subjects aged 18\u201360 years, diagnosed with long covid were included. We excluded pregnant women, patients with RAND-36 (role limitations due to physical health (RP) and physical functioning (PF)) above 70, diabetes, hypertension and contraindications for HBOT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Subjects were randomly assigned to 10 sessions of HBOT or sham (placebo) treatments over 6\u2009weeks. HBOT involved 100% oxygen, 2.4\u2009bar, 90\u2009min, placebo medical air, 1.34\u20131.2\u2009bar. Randomisation (1:1) was done electronically, in blocks stratified by sex and disease severity. Subjects and investigators were blinded to allocation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Primary endpoints were changes from baseline in RAND-36 PF and RP at 13 weeks. Efficacy was analysed on an intention-to-treat basis. Harms were evaluated according to the actual treatment given.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 15 September 2021 and 20 June 2023, 80 subjects (65\u2009women, 15 men) were enrolled and randomised (40 in each group). The trial is completed. The primary endpoint analysis included 79 subjects (40 in HBOT and 39 in control). At 13 weeks, both groups showed improvement, with no significant difference between HBOT and placebo in PF (least square mean difference between groups (LSD), 0.63 (95% CI \u22127.04 to 8.29), p=0.87) and RP (LSD, 2.35 (95% CI \u22125.95 to 10.66), p=0.57). Harms: 43 adverse events (AEs), most commonly cough and chest pain\/discomfort, occurred in 19 subjects (49%) of the HBOT group and 38 AEs in 18 subjects (44%) of the placebo group, one serious AE in HBOT and one death in the placebo group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>10 HBOT sessions did not show more short-term benefits than placebo for long covid patients. Both groups improved, with a notable sex difference. HBOT has a favourable harm profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04842448\">NCT04842448<\/jats:ext-link>\n                      ), EudraCT (2021-000764-30). The trial was funded by Vetenskapsr\u00e5det (2022-00834), Region Stockholm (2020-0731, 2022-0674), Hj\u00e4rt-Lungfonden and OuraHealth Oy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-094386","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:50:28Z","timestamp":1744631428000},"page":"e094386","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Ten sessions of hyperbaric oxygen versus sham treatment in patients with long covid (HOT-LoCO): a randomised, placebo-controlled, double-blind, phase II trial"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct04842448","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04842448","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4819-1024","authenticated-orcid":false,"given":"Anders","family":"Kjellberg","sequence":"first","affiliation":[{"name":"Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden"},{"name":"Perioperative Medicine and Intensive Care, Medical Unit Intensive Care and Thoracic Surgery, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hassler","sequence":"additional","affiliation":[{"name":"Medical Unit Emergency Medicine, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6922-7631","authenticated-orcid":false,"given":"Emil","family":"Bostr\u00f6m","sequence":"additional","affiliation":[{"name":"Medical Unit Emergency Medicine, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-1839","authenticated-orcid":false,"given":"Sara","family":"El Gharbi","sequence":"additional","affiliation":[{"name":"Medical Unit Emergency Medicine, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5940-6182","authenticated-orcid":false,"given":"Sarah","family":"Al-Ezerjawi","sequence":"additional","affiliation":[{"name":"Medical Unit Emergency Medicine, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schening","sequence":"additional","affiliation":[{"name":"Perioperative Medicine and Intensive Care, Medical Unit Intensive Care and Thoracic Surgery, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"},{"name":"Medical Unit Cardiology, Heart and Vascular Center, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H","family":"Kowalski","sequence":"additional","affiliation":[{"name":"JK Biostatistics AB, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-6181","authenticated-orcid":false,"given":"Kenny A","family":"Rodriguez-Wallberg","sequence":"additional","affiliation":[{"name":"Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bruchfeld","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"St\u00e5hlberg","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"},{"name":"Medical Unit Cardiology, Heart and Vascular Center, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Nygren-Bonnier","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden"},{"name":"Women\u2019s Health and Allied Health Professionals Theme, Medical Allied Health Professionals, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Runold","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Respiratory Medicine Unit, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0840-9244","authenticated-orcid":false,"given":"Peter","family":"Lindholm","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Emergency Medicine, Division of Hyperbaric Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"2025121220070240000_15.4.e094386.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00846-2"},{"key":"2025121220070240000_15.4.e094386.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00703-9\/ATTACHMENT\/31179DEC-CF64-455B-BD13-6EF0045B7DD6\/MMC1.PDF"},{"key":"2025121220070240000_15.4.e094386.3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13584"},{"key":"2025121220070240000_15.4.e094386.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01136-X"},{"key":"2025121220070240000_15.4.e094386.5","unstructured":"Ladyzhets B . Underwhelming\u201d: NIH trials fail to test meaningful long Covid treatments\u2014after 2\u00b75 years and $1 billion. Stat News 2023. Available: https:\/\/www.statnews.com\/2023\/08\/09\/long-covid-nih-trials\/"},{"key":"2025121220070240000_15.4.e094386.6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107105","article-title":"The global clinical studies of long COVID","volume":"146","author":"Ramonfaur","year":"2024","journal-title":"Int J Infect Dis"},{"key":"2025121220070240000_15.4.e094386.7","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)02798-7","article-title":"Long COVID and self-management","volume":"399","author":"Brown","year":"2022","journal-title":"Lancet"},{"key":"2025121220070240000_15.4.e094386.8","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57090864","article-title":"A General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational Opportunities","volume":"57","author":"Ortega","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"2025121220070240000_15.4.e094386.9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/ACO.0000000000000773","article-title":"Emerging indications for hyperbaric oxygen","volume":"32","author":"Bennett","year":"2019","journal-title":"Curr Opin Anaesthesiol"},{"key":"2025121220070240000_15.4.e094386.10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15565-0","article-title":"Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial","volume":"12","author":"Zilberman-Itskovich","year":"2022","journal-title":"Sci Rep"},{"key":"2025121220070240000_15.4.e094386.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-36570-x","article-title":"The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trial","volume":"13","author":"Leitman","year":"2023","journal-title":"Sci Rep"},{"key":"2025121220070240000_15.4.e094386.12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-53091-3","article-title":"Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a randomized controlled trial","volume":"14","author":"Hadanny","year":"2024","journal-title":"Sci Rep"},{"key":"2025121220070240000_15.4.e094386.13","first-page":"197","article-title":"The efficacy of hyperbaric oxygen therapy in the management of chronic fatigue syndrome","volume":"40","author":"Akarsu","year":"2013","journal-title":"Undersea Hyperb Med"},{"key":"2025121220070240000_15.4.e094386.14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12196253","article-title":"Immediate and Long-Term Effects of Hyperbaric Oxygenation in Patients with Long COVID-19 Syndrome Using SF-36 Survey and VAS Score: A Clinical Pilot Study","volume":"12","author":"Lindenmann","year":"2023","journal-title":"J Clin Med"},{"key":"2025121220070240000_15.4.e094386.15","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1354088","article-title":"Hyperbaric oxygen effectively addresses the pathophysiology of long COVID: clinical review","volume":"11","author":"Katz","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"2025121220070240000_15.4.e094386.16","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107744","article-title":"Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial","volume":"232","author":"Kjellberg","year":"2024","journal-title":"Respir Med"},{"key":"2025121220070240000_15.4.e094386.17","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12122043","article-title":"Comparing the Blood Response to Hyperbaric Oxygen with High-Intensity Interval Training-A Crossover Study in Healthy Volunteers","volume":"12","author":"Kjellberg","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"2025121220070240000_15.4.e094386.18","unstructured":"U.S Food and Drug Administration . Hyperbaric Oxygen Therapy: Get the Facts, 2021. Available: https:\/\/www.fda.gov\/consumers\/consumer-updates\/hyperbaric-oxygen-therapy-get-facts"},{"key":"2025121220070240000_15.4.e094386.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081318","article-title":"Interventions for the management of long covid (post-covid condition): living systematic review","volume":"387","author":"Zeraatkar","year":"2024","journal-title":"BMJ"},{"key":"2025121220070240000_15.4.e094386.20","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28289","article-title":"Clinical trials on the pharmacological treatment of long COVID: A systematic review","volume":"95","author":"Chee","year":"2023","journal-title":"J Med Virol"},{"key":"2025121220070240000_15.4.e094386.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.21903"},{"key":"2025121220070240000_15.4.e094386.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061870","article-title":"Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial","volume":"12","author":"Kjellberg","year":"2022","journal-title":"BMJ Open"},{"key":"2025121220070240000_15.4.e094386.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073725","article-title":"CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials","volume":"381","author":"Junqueira","year":"2023","journal-title":"BMJ"},{"key":"2025121220070240000_15.4.e094386.24","doi-asserted-by":"publisher","DOI":"10.1177\/1740774518776952"},{"key":"2025121220070240000_15.4.e094386.25","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.7861\/clinmed.2021-0462","article-title":"Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention","volume":"21","author":"Robbins","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"2025121220070240000_15.4.e094386.26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-44432-3","article-title":"Muscle abnormalities worsen after post-exertional malaise in long COVID","volume":"15","author":"Appelman","year":"2024","journal-title":"Nat Commun"},{"key":"2025121220070240000_15.4.e094386.27","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1447742","article-title":"Optimizing hyperbaric oxygen therapy for PTSD-The importance of dose and duration for sustained benefits","volume":"15","author":"Doenyas-Barak","year":"2024","journal-title":"Front Neurol"},{"key":"2025121220070240000_15.4.e094386.28","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.000000000000010311"},{"key":"2025121220070240000_15.4.e094386.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007004","article-title":"Conceptualising Long COVID as an episodic health condition","volume":"6","author":"Brown","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2025121220070240000_15.4.e094386.30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S2213-2600(23)00370-3","article-title":"Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study","volume":"11","author":"Gorst","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2025121220070240000_15.4.e094386.31","doi-asserted-by":"publisher","DOI":"10.1002\/JMV.27309"},{"key":"2025121220070240000_15.4.e094386.32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38388-7","article-title":"Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program","volume":"14","author":"Brannock","year":"2023","journal-title":"Nat Commun"},{"key":"2025121220070240000_15.4.e094386.33","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad382"},{"key":"2025121220070240000_15.4.e094386.34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.27128","article-title":"Neurologic Manifestations of Long COVID Disproportionately Affect Young and Middle-Age Adults","volume":"97","author":"Choudhury","year":"2025","journal-title":"Ann Neurol"},{"key":"2025121220070240000_15.4.e094386.35","unstructured":"European Medicines Agency . [ICH-GCP Guidelines] ICH guideline for good clinical practice E6(R2), 2016. Available: https:\/\/www.ema.europa.eu\/en\/ich-e6-r2-good-clinical-practice-scientific-guideline#current-version--section"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-094386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:07:10Z","timestamp":1765598830000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-094386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,14]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/bmjopen-2024-094386"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094386","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}